about
Bisphosphonates for osteoporosis in primary biliary cirrhosisBisphosphonates for osteoporosis in primary biliary cirrhosisHepatic osteodystrophyLow bone mineral density in chronic hepatitis B virus infection: A case-control study.Viral hepatitis is associated with reduced bone mineral density in HIV-infected women but not menHepatic osteodystrophy and liver cirrhosis.Low bone mineral density and the severity of cholestasis in biliary atresia.The effect of HIV-hepatitis C co-infection on bone mineral density and fracture: a meta-analysis.Bone disorders in children and adolescents with chronic HCV infection.Bone disease in patients with primary sclerosing cholangitisRisk of hip fracture associated with untreated and treated chronic hepatitis B virus infectionExtrahepatic manifestations of cholestasis.Liver function parameters in hip fracture patients: relations to age, adipokines, comorbidities and outcomes.Reduced bone mineral density and altered bone turnover markers in patients with non-cirrhotic chronic hepatitis B or C infection.Bone mineralization in children with Wilson's disease.Osteoporosis and bone fractures in alcoholic liver disease: a meta-analysis.The factors affecting bone density in cirrhosis.Hepatic osteodystrophy: An important matter for consideration in chronic liver disease.Structural Bone Deficits in HIV/HCV-Coinfected, HCV-Monoinfected, and HIV-Monoinfected WomenIncreased risk of hip fracture associated with dually treated HIV/hepatitis B virus coinfectionRisk of hip fracture associated with hepatitis C virus infection and hepatitis C/human immunodeficiency virus coinfection.Is osteoporosis a peculiar association with primary biliary cirrhosis?Pegylated interferon α/ribavirin therapy enhances bone mineral density in children with chronic genotype 4 HCV infection.Liver disease and osteoporosis.Prospective study of profile of hepatic osteodystrophy in patients with non-choleastatic liver cirrhosis and impact of bisphosphonate supplementation.Vitamin D replacement for cirrhosis-related bone disease.Osteoporosis and fractures in HIV/hepatitis C virus coinfection: a systematic review and meta-analysis.Study of Hepatic Osteodystrophy in Patients with Chronic Liver Disease.Bone mineral densities in individuals with Gilbert's syndrome: a cross-sectional, case-control pilot study.Association Between Chronic Hepatitis B Virus Infection and Risk of Osteoporosis: A Nationwide Population-Based Study.Increased bone mineral density in patients with non-alcoholic steatohepatitis.Long-term outcome after liver transplantation.Testosterone in men with advanced liver disease: abnormalities and implications.Osteoporosis across chronic liver disease.Hepatitis C virus coinfection as a risk factor for osteoporosis and fracture.Males seropositive for hepatitis B surface antigen are at risk of lower bone mineral density: the 2008-2010 Korea National Health and Nutrition Examination Surveys.Long-term safety of oral nucleos(t)ide analogs for patients with chronic hepatitis B: A cohort study of 53,500 subjects.Areal bone mineral density in pediatric patients with chronic hepatitis B or chronic hepatitis C.Prevalence of causes of secondary osteoporosis and contribution to lower bone mineral density in HIV-infected patients.Bone mineral metabolism and histomorphometry in rats with cholestatic liver disease.
P2860
Q24234283-61177B74-0701-4954-A9A6-812D9E691F16Q24234967-BC662E5D-FC17-41AA-8746-B96322D10663Q27004571-AC58F8DE-0880-4F9A-B0C7-8113B137B0B5Q33690431-7C026054-FC5E-4C2B-A00D-DE7C9EFB23DFQ33722412-BFF1F1B0-FB4F-4127-B20F-86C7EBC4EA2DQ33764798-DEE0DE15-243F-40BB-8584-96B8A7B318F7Q33789877-66B6C93C-7DA2-419B-BBB3-8B2762F24D5AQ33916243-3B5F5974-3D79-49EA-B577-18305C11A69EQ34230367-46F7C345-88A4-48D2-BE4D-52134DED3888Q34597311-F91BD3D5-8586-4099-ACFC-11247C0988FFQ34670561-7CFCFC78-3E15-42CC-8841-7BD478F7E0A1Q34776437-C8D8B9F8-E554-433C-8419-3298239938C9Q34942815-099BD6A4-EE01-499F-B515-B0F0E77E4782Q35011138-4786B9A6-DAB6-4FD3-A68D-8EC1E6E40A62Q35173677-C79E6732-E2F1-4721-BB02-CDEB33336278Q35270537-B65B27FC-FA06-4607-BA4F-36B289506880Q35595589-F864A182-4AE8-432D-B28A-47E3C09CD373Q35635642-302D49F6-4B8D-4E89-A141-F88F103D766EQ35993503-D564A6F3-24D3-405F-A03E-FB33B8A1B0C2Q36031673-A71D0888-C44F-4425-9DC3-F2130C9E4747Q36208036-E68B8D70-56F8-4132-9FBB-4CE484B1AD83Q36213979-78516BF5-8D00-4FB7-83CB-59BACF2246A1Q36263107-7C984DA2-60A9-4265-8A7C-0FE10682A230Q36506087-813F2A89-B5D2-475C-A905-5C3EECE16310Q36616083-10822469-4A0D-40D6-82B3-7A551632BB0EQ36666317-49B8BA32-EF51-4FC8-80DF-754599D01ECFQ37085238-F1F53A70-5A3B-4A47-A57F-241B0A8007CEQ37266496-1146E25A-7888-473A-B35D-680638AC0474Q37291701-1504DE8E-8C9B-4BFE-95E2-63D5C89F28B5Q37328367-5FB580C3-0622-40F7-93E2-2D260B1138E5Q37358283-E8F500B1-17CB-462D-9EB9-D17095DCB9BDQ38002368-F6EF1245-66AD-4C7A-9C42-DC2818C66D9EQ38236451-7559F1D7-E682-413B-A084-47E3DA88A462Q38723451-8F27DD48-FD1D-4D63-8237-A2E2665575D0Q38738823-90E3034B-93D0-463A-936A-61A4B25DAD7AQ38911526-77602CCA-0AAC-4D6D-8EAB-9F0ECC7C6910Q40940224-3DF80F51-BEEC-4836-82E5-E53569B3AF51Q42210469-20E8A5D7-A800-4BAF-AF3A-CE2FDC8D28B8Q42246883-8D44CCAC-2225-4578-B2C8-17CC72F241D2Q44004771-9D2A5006-182A-4FDD-93DF-9A871EDA386D
P2860
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Hepatic osteodystrophy.
@ast
Hepatic osteodystrophy.
@en
Hepatic osteodystrophy.
@nl
type
label
Hepatic osteodystrophy.
@ast
Hepatic osteodystrophy.
@en
Hepatic osteodystrophy.
@nl
prefLabel
Hepatic osteodystrophy.
@ast
Hepatic osteodystrophy.
@en
Hepatic osteodystrophy.
@nl
P356
P1433
P1476
Hepatic osteodystrophy.
@en
P2093
P304
P356
10.1053/JHEP.2001.20533
P407
P577
2001-01-01T00:00:00Z